CARM logo

Carisma Therapeutics (CARM) Company Overview

Profile

Full Name:

Carisma Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 6, 2014

Indexes:

Not included

Description:

CARM (Carisma Therapeutics) is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They use engineered immune cells to target and destroy tumors, aiming to improve patient outcomes and provide new options for cancer care. Their approach combines advanced science with personalized medicine.

Key Details

Price

$0.45

Annual Revenue

$14.92 M(+51.71% YoY)

Annual EPS

-$2.59(-70.28% YoY)

Annual ROE

-327.45%

Beta

1.36

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Mar 8, 2023
Splits

Next split:

N/A

Recent split:

Mar 8, 2023

Analyst ratings

Recent major analysts updates

Jan 17, 25 D. Boral Capital
Buy
Jan 13, 25 D. Boral Capital
Buy
Dec 16, 24 HC Wainwright & Co.
Neutral
Dec 12, 24 D. Boral Capital
Buy
Dec 12, 24 Baird
Neutral
Dec 11, 24 Evercore ISI Group
In-Line
Dec 10, 24 BTIG
Neutral
Dec 9, 24 D. Boral Capital
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Nov 18, 24 D. Boral Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Carisma Therapeutics?
  • Does Carisma Therapeutics pay dividends?
  • What sector is Carisma Therapeutics in?
  • What industry is Carisma Therapeutics in?
  • What country is Carisma Therapeutics based in?
  • When did Carisma Therapeutics go public?
  • Is Carisma Therapeutics in the S&P 500?
  • Is Carisma Therapeutics in the NASDAQ 100?
  • Is Carisma Therapeutics in the Dow Jones?
  • When was Carisma Therapeutics's last earnings report?
  • When does Carisma Therapeutics report earnings?
  • Should I buy Carisma Therapeutics stock now?

What is the ticker symbol for Carisma Therapeutics?

The ticker symbol for Carisma Therapeutics is NASDAQ:CARM

Does Carisma Therapeutics pay dividends?

No, Carisma Therapeutics does not pay dividends

What sector is Carisma Therapeutics in?

Carisma Therapeutics is in the Healthcare sector

What industry is Carisma Therapeutics in?

Carisma Therapeutics is in the Biotechnology industry

What country is Carisma Therapeutics based in?

Carisma Therapeutics is headquartered in United States

When did Carisma Therapeutics go public?

Carisma Therapeutics's initial public offering (IPO) was on February 6, 2014

Is Carisma Therapeutics in the S&P 500?

No, Carisma Therapeutics is not included in the S&P 500 index

Is Carisma Therapeutics in the NASDAQ 100?

No, Carisma Therapeutics is not included in the NASDAQ 100 index

Is Carisma Therapeutics in the Dow Jones?

No, Carisma Therapeutics is not included in the Dow Jones index

When was Carisma Therapeutics's last earnings report?

Carisma Therapeutics's most recent earnings report was on Nov 7, 2024

When does Carisma Therapeutics report earnings?

The next expected earnings date for Carisma Therapeutics is Apr 1, 2025

Should I buy Carisma Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions